Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

Published:2024-03 Issue:3 Volume:5 Page:100645
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Cheung Justin M.,Kang Jiyoon,Yeap Beow Y.,Peterson Jennifer L.,Do Andrew,Gainor Justin F.,Digumarthy Subba R.,Lin Jessica J.^ORCID

Funder

National Institutes of Health

Massachusetts General Hospital

Publisher

Elsevier BV

Reference21 articles.

1. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK;Shaw;J Clin Oncol,2009

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small-cell lung cancer;Gainor;JCO Precis Oncol,2017

4. Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET-rearranged lung cancers;Drilon;J Thorac Oncol,2018

5. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases;Ali;Curr Oncol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance;Frontiers in Immunology;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP